Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 221

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 7
Chunk 221
---
,839

    11,617

    (778
    )

    Software and cloud services expenses

    4,908

    3,394

    1,514

    Depreciation and other expenses

    8,620

    12,478

    (3,858
    )

    Total
     
    $
    102,953

    $
    122,117

    $
    (19,164
    )

The $19.2 million decrease in research and development expenses was primarily attributable to an $11.6 million decrease in personnel costs and a $4.4 million decrease in laboratory materials and allocated production laboratory expenses, which was driven primarily by decreased investments in drug discovery efforts, including collaboration efforts with Genentech, and decreased investments in TCR-antigen binding development activities, partially offset by an increase in investments related to the MRD business. There was also a $3.9 million decrease in depreciation and other expenses, inclusive of a $2.6 million decrease in costs related to collaboration studies primarily related to Immune Medicine, and a $0.8 million decrease in allocable facilities expenses. These decreases were partially offset by a $1.5 million increase in software and cloud services expenses. 

Sales and Marketing

    Year Ended December 31,

    Change
     
    Percent of Revenue

    (in thousands, except percentages)
     
    2024

    2023

    $

    %
     
    2024

    2023

    Sales and marketing
     
    $
    84,759

    $
    88,579

    $
    (3,820
    )
     
    (4)%

    47
    %

    52
    %

79

The $3.8 million decrease in sales and marketing expenses was primarily attributable to a $4.1 million decrease in personnel costs and a $2.0 million decrease in marketing expenses, which was largely driven by reduced clonoSEQ marketing activities, followed by reduced research and corporate marketing activities. There was also a $0.8 million decrease in travel and customer event related expenses. These decreases were partially offset by a $2.1 million increase in computer and software expenses and a $1.1 million increase in allocated facility and overhead expenses.

General and Administrative

    Year Ended December 31,

    Change
     
    Percent of Revenue

    (in thousands, except percentages)